BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23390291)

  • 1. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
    Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
    J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
    Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
    Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
    Kim DD; Miwa T; Song WC
    J Immunol; 2006 Oct; 177(8):5558-66. PubMed ID: 17015743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.
    Kim DD; Miwa T; Kimura Y; Schwendener RA; van Lookeren Campagne M; Song WC
    Blood; 2008 Aug; 112(4):1109-19. PubMed ID: 18524992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane protein Crry maintains homeostasis of the complement system.
    Wu X; Spitzer D; Mao D; Peng SL; Molina H; Atkinson JP
    J Immunol; 2008 Aug; 181(4):2732-40. PubMed ID: 18684964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
    Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
    Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
    Renner B; Coleman K; Goldberg R; Amura C; Holland-Neidermyer A; Pierce K; Orth HN; Molina H; Ferreira VP; Cortes C; Pangburn MK; Holers VM; Thurman JM
    J Immunol; 2010 Sep; 185(5):3086-94. PubMed ID: 20675597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
    Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
    Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
    Laskowski J; Renner B; Le Quintrec M; Panzer S; Hannan JP; Ljubanovic D; Ruseva MM; Borza DB; Antonioli AH; Pickering MC; Holers VM; Thurman JM
    Kidney Int; 2016 Jul; 90(1):109-22. PubMed ID: 27165610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
    Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broader expression of the mouse platelet factor 4-cre transgene beyond the megakaryocyte lineage.
    Pertuy F; Aguilar A; Strassel C; Eckly A; Freund JN; Duluc I; Gachet C; Lanza F; Léon C
    J Thromb Haemost; 2015 Jan; 13(1):115-25. PubMed ID: 25393502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.
    Miwa T; Zhou L; Kimura Y; Kim D; Bhandoola A; Song WC
    Blood; 2009 Mar; 113(12):2684-94. PubMed ID: 19136662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
    Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
    J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
    Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
    Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
    Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
    Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
    Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
    Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.